Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Funding Opportunities
    • Information for Applicants
    • Researcher Resources
    • Our Review Process
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • CIRM Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Neural stem cell transplantation for chronic cervical spinal cord injury

  • Post author:
  • Post published:November 8, 2025
  • Post category:

1.3 million Americans suffer chronically from spinal cord injuries (SCI); each year ~15,000 individuals sustain a new injury. For California, this means nearly 147,000 individuals are living with a SCI…

Continue ReadingNeural stem cell transplantation for chronic cervical spinal cord injury

Treatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells

  • Post author:
  • Post published:November 8, 2025
  • Post category:

Although most individuals are aware that osteoporosis is disease of increased bone fragility that results from estrogen deficiency and aging, most are unaware of the high risk and cost of…

Continue ReadingTreatment of non-traumatic osteonecrosis with endogenous Mesenchymal stem cells

Stem cell based small molecule therapy for Alzheimer’s disease

  • Post author:
  • Post published:November 8, 2025
  • Post category:

Over 6 million people in the US suffer from AD. There are no drugs that prevent the death of nerve cells in AD, nor has any drug been identified that…

Continue ReadingStem cell based small molecule therapy for Alzheimer’s disease

Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

  • Post author:
  • Post published:November 8, 2025
  • Post category:

While current treatment strategies for high-grade glioma can yield short term benefits, their inability to eradicate the highly tumorigenic cancer stem cell population results in disease recurrence in the vast…

Continue ReadingTargeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells

Direct Cardiac Reprogramming for Heart Regeneration

  • Post author:
  • Post published:November 8, 2025
  • Post category:

Heart disease is a leading cause of mortality. The underlying pathology is typically loss of heart muscle cells that leads to heart failure. Because heart muscle has little or no…

Continue ReadingDirect Cardiac Reprogramming for Heart Regeneration

Identifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

  • Post author:
  • Post published:November 8, 2025
  • Post category:

We propose to discover new drug candidates for Alzheimer’s Disease (AD), which is common, fatal, and for which no effective disease-modifying drugs are available. Because no effective AD treatment is…

Continue ReadingIdentifying Drugs for Alzheimer’s Disease with Human Neurons Made From Human IPS cells

Human ES cell based therapy of heart failure without allogenic immune rejection

  • Post author:
  • Post published:November 8, 2025
  • Post category:

Heart failure is a major and ever-growing health problem affecting an estimated 5.8 million Americans with about half a million new cases every year. There are limited therapeutic options for…

Continue ReadingHuman ES cell based therapy of heart failure without allogenic immune rejection

Heart Repair with Human Tissue Engineered Myocardium

  • Post author:
  • Post published:November 8, 2025
  • Post category:

Heart disease is the number one cause of morbidity and mortality in the US. With an estimated 1.5 million new or recurrent myocardial infarctions, the total economic burden on our…

Continue ReadingHeart Repair with Human Tissue Engineered Myocardium

Gene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID

  • Post author:
  • Post published:November 8, 2025
  • Post category:

Artemis is a chemical in all cells in the body that is essential for the normal development of the immune system and repairing damaged DNA. Artemis deficiency (AD) causes Severe…

Continue ReadingGene Correction of Autologous Hematopoietic Stem Cells in Artemis Deficient SCID

Local Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients

  • Post author:
  • Post published:November 8, 2025
  • Post category:

As humans age, the ability to regenerate skeletal muscle tissue is impaired. Injuries to the musculoskeletal system that require extended periods of immobilization lead to muscle atrophy and are particularly…

Continue ReadingLocal Delivery of Rejuvenated Old Muscle Stem Cells to Increase Strength in Aged Patients
  • Go to the previous page
  • 1
  • …
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • …
  • 57
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us